- Drugs
- Wednesday, 22 Apr 2020
Applied BioMath, LLC Announces Collaboration with Northern Biologics
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Northern Biologics for semi-mechanistic pharmacokinetic and pharmacodynamic (PK/PD) modeling of Northern Biologics' lead preclinical antibody for the treatment of cancer. Northern Biologics will leverage Applied Biomath's modelling expertise to strengthen their understanding of key biological and preclinical parameters that will help inform selection of clinical starting dose. "The accurate prediction of appropriate clinical doses based on preclinical data is important and challenging" said Joanne Hulme, VP, Head of Research at Northern Biologics. "We decided to collaborate with Applied BioMath given their proven track record of helping teams accurately translate preclinical PK/PD data to first-in-human studies."
Applied BioMath employs a rigorous fit-for-purpose model development process which aims to quantitatively integrate knowledge about therapeutics with an understanding of its mechanism of action in the context of human disease mechanisms. Their approach provides objective insight to support decision-making throughout discovery, development, and into the clinic enabling project teams to utilize experiments and resources more efficiently. "There are many factors to consider when translating PK/PD from preclinical species to human, such as cell lines of interest, receptors per cell per cell line, the presence of target-mediated drug disposition, etc." said Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath. "Our modeling approach incorporates biophysical parameters related to all of these factors which enables us to accurately predict clinical starting doses."
Related Industry Updates
OTC Drug and Dietary Supplement Market In-depth Research Analysis By The Insight Partners
Jan 05, 2021
UnitedHealth rises on 'minimal' COVID-19 impact on results & maintained its forecast
Apr 15, 2020
Canna Hemp and The Growing Demand for Quality CBD Wellness Products
Mar 20, 2020
Infectious Disease Therapeutics Market is expected to reach US$ 1,67,883.93 million by 2030
Jan 25, 2024
Novartis scraps sale of assets including COVID-19 hopeful to Indis's Aurobindo Pharma
Apr 02, 2020
Liberty Health Sciences and iHeartJane Partner to Offer Patients a Real-Time Inventory Online Shopping Experience
Jan 22, 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
May 15, 2020